Advances in Oncology, 2023, 1st Edition
特長
- Contains 25 articles on such topics as de-escalation therapy for HPV-associated oropharyngeal cancer; management of in-transit metastatic melanoma; rare gynecologic tumors; pediatric lymphoma: advances with an eye on disparities; the microbiome and CNS tumors; adjuvant therapy for patients with high-risk urothelial cancer following surgery; targeting the RAS gene for treatment of GI cancers; and more
- Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice
- Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews
著者情報
| ISBN Number | 9780443182709 |
|---|---|
| Description Author List | Edited by Leonidas C. Platanias, M.D., Ph.D, Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics, USA |
| Copyright Year | 2024 |
| Edition Number | 1 |
| Format | Book |
| Trim | 191w x 235h (7.50" x 9.25") |
| Imprint | Elsevier |
| Page Count | 240 |
| Publication Date | 17 Apr 2023 |
| Stock Status | IN STOCK |
eBooks : Built for busy schedules & tailored for your goals.
Affordable knowledge, built for you
Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.
Seamless access wherever you are
Always in sync
Tools the make learning stick
Your eBook is ready whenever you are!
1. Check your email for your access code.
2. Sign into or create your VitalSource account and redeem your code.
3. Open your eBook - ready whenever you are!
FAQ
The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop. If you do not receive your code within a few minutes, please check your spam folder.
Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.
The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.
You will have unlimited access to your eBook on the device to which it was downloaded.
Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.
Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.
Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.
You can return your eBook within 13 days of purchase. eBooks that have been partially printed or flipped through more than 15% are excluded from returns.
Any questions ?
Top Picks from Our Community
SECTION I: RADIATION ONCOLOGY
1. De-escalation for Human Papillomavirus–Associated Oropharyngeal Cancer: A Comprehensive Review
2. Treatment of Endometrial Cancer: Updates and Future Directives
SECTION II: SURGICAL ONCOLOGY
3. Remote Telemonitoring and Telehealth in Surgical Oncology
4. Management of In-Transit Metastatic Melanoma
5. Contemporary Management of Merkel Cell Carcinoma
SECTION III: GYNECOLOGIC ONCOLOGY
6. Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets
7. Advances in Cervical Cancer
SECTION IV: PEDIATRIC ONCOLOGY
8. Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations
SECTION V: NEURO-ONCOLOGY
9. Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas
10. Updates on Role for and Efficacy of Laser Interstitial Thermal Therapy in the Management of Brain Tumors
11. The Microbiome and Central Nervous System Tumors
SECTION VI: HEMATOLOGICAL
12. ONCOLOGY Moving Toward a Chemotherapy-Free Approach for Philadelphia-Chromosome>Positive Acute Lymphoblastic Leukemia
13. Inherited Predisposition to Hematopoietic
14. Malignancies: Advances Made in the Diagnosis and Management of Hereditary Hematopoietic Malignancies in the Era of Next-Generation Sequencing Technologies
SECTION VII: URO-ONCOLOGY
15. The Future of Radioligand Therapies in Metastatic Castrate-Resistant Prostate Cancer
16. The Future of Antibody–Drug Conjugates in Urothelial Cancer: New Indications and Novel Targets
SECTION VIII: GASTROINTESTINAL
17. ONCOLOGY Targeting Rat Sarcoma Viral Oncogene Homolog for Treatment of Gastrointestinal Cancers
18. Recent Clinical Advances in Rare Gastrointestinal Tumors: Anal, Small Intestine, and Appendix Cancers
19. Gastrointestinal Cancers and the Link to the Microbiome
